- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03591211
Bio-psycho-social Pathways Underlying the Effects of Qigong Among Comorbid Depressed Elderly With Chronic Conditions
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hong Kong, Hong Kong
- The Hong Kong Polytechinic University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- aged 60 or above
- have been suffering from chronic medical conditions for more than one year
- have depressive symptoms as indicated by Geriatric Depression Scale (GDS ≥ 6)
Exclusion Criteria:
- have practiced or received training of any form of mind-body exercises (including tai chi, yoga, and qigong) during the 6 months prior to intervention.
- have changed medication or the dosage prior to or during intervention
- have obvious cognitive and language impairment or score less than 20 in Mini-Mental State Examination (MMSE)
- undergo electroconvulsive therapy, psychotherapy, or psychoeducation
- cannot demonstrate satisfactory sitting balance
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Cognitive Training
|
Cognitive Training of Memory and Executive Function with Activities requiring Mobilization
|
|
Experimental: Qigong Training
|
Eight-Section Brocades; participants were trained individually.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire (PHQ)
Time Frame: the change from baseline to the completion of intervention (12 weeks later)
|
Patient Health Questionnaire (PHQ) is used to assess the experience of depressive symptoms.
The frequency of each symptom was indicated based on a 4-point scale (0 = never; 3 = almost every day).
A total score ranged from 0 to 27 can be derived, with higher score indicating severer depressive symptoms.
|
the change from baseline to the completion of intervention (12 weeks later)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Salivary Cortisol Level
Time Frame: baseline and 12 weeks after baseline
|
measured with saliva sample obtained 5 times (07:00, 10:30, 13:00, 14:30, and 18:00) at two consecutive days at baseline and 12 weeks after baseline
|
baseline and 12 weeks after baseline
|
|
Brain Deprived Neurotrophic Factor (BDNF) Level
Time Frame: baseline and 12 weeks after baseline
|
measured with peripheral blood samples (10 ml) collected in the morning
|
baseline and 12 weeks after baseline
|
|
Serotonin 5-HT Level
Time Frame: baseline and 12 weeks after baseline
|
measured with serum extracted from blood samples.
Around 2-3 ml of serum is harvested per 5 ml of blood.
|
baseline and 12 weeks after baseline
|
|
Depression Anxiety Stress Scale (DASS-21)
Time Frame: baseline, 12 weeks after baseline, and 16 weeks after baseline
|
Depression Anxiety Stress Scale (DASS-21) is a 21-item scale to measure symptoms of depression, anxiety, and stress with 7 items for each.
Each item is measured with 4-point from 0 (never) to 3 (almost always).
The scores of depression, anxiety, and stress are the sum of all subscale items, and it can range from 0 to 21.
Higher score shows more severity of depression, anxiety, and stress.
|
baseline, 12 weeks after baseline, and 16 weeks after baseline
|
|
Personal Well-Being Index (PWI)
Time Frame: baseline, 12 weeks after baseline, and 16 weeks after baseline
|
It is measured by the 8-item scale of Personal Well-Being Index (PWI).
Each item was rated according to an 11-point scale ranging from '0' (extremely dissatisfied) to '10' (extremely satisfied).
An overall score of PWI score was the sum of all items.
The overall score ranges from 0 to 110, with higher score indicating higher subjective well-being.
|
baseline, 12 weeks after baseline, and 16 weeks after baseline
|
|
Functional Independence Measure (FIM)
Time Frame: baseline, 12 weeks after baseline, and 16 weeks after baseline
|
It is measured by the 18-item scale of Functional Independence Measure (FIM). Based on a 7-point scale for rating (1 = totally unable; 7 = totally independent), a total score of FIM ranges from 18 to 126 was generated. Higher total score indicates less disability. |
baseline, 12 weeks after baseline, and 16 weeks after baseline
|
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: baseline, 12 weeks after baseline, and 16 weeks after baseline
|
It is measured by the Pittsburgh Sleep Quality Index (PSQI).
It has 19 items measuring 7 components of sleep quality, and a total score is calculated as the sum of all the component scores.
The total score ranges from 0 to 21, with lower score showing better sleep quality.
|
baseline, 12 weeks after baseline, and 16 weeks after baseline
|
|
Timed up and Go Test (TUG)
Time Frame: baseline, 12 weeks after baseline, and 16 weeks after baseline
|
Timed up and Go Test (TUG) is used to measure mobility. During the test, participants were sitting on a chair, and then they were required to stand up, walk to a mark which is 3 meters away from the chair, go back to the chair from the mark, and sit down again. The time each participant spent to complete the above series of actions was recorded. Participants performed the test for three times, and their final scores were the average of the three. And lower score indicates better mobility. |
baseline, 12 weeks after baseline, and 16 weeks after baseline
|
|
Handgrip Strength
Time Frame: baseline, 12 weeks after baseline, and 16 weeks after baseline
|
It is measured with a Jamar handheld dynamometer.
Participants performed three trials of left hand and right hand grip strength, and the final outcome of each hand was calculated as the mean performance of the three trials.
Higher score indicates stronger handgrip strength.
|
baseline, 12 weeks after baseline, and 16 weeks after baseline
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 81173316-2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsRecruitingChronic Disease | Chronic Conditions, Multiple | Chronic ConditionDenmark
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsCompletedChronic Conditions, Multiple | Chronic ConditionDenmark
-
Radboud University Medical CenterRecruitingChronic Conditions, Multiple | Chronic ConditionNetherlands
-
Radboud University Medical CenterCompleted
-
University of LimerickCompletedChronic Conditions, MultipleIreland
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
Clinical Trials on Qigong Training
-
The Hong Kong Polytechnic UniversityFujian University of Traditional Chinese MedicineCompletedChronic Disease | Depressive SymptomsHong Kong
-
Dartmouth-Hitchcock Medical CenterCompletedFalls, Balance Self-confidenceUnited States
-
The Hong Kong Polytechnic UniversityNot yet recruitingIntervention | Waitlist Control
-
Akdeniz UniversityCompletedQuality of Life | Postoperative Pain | Muscle Weakness | Pain, Shoulder | Respiratory Function Loss | Joint AdhesionTurkey
-
Riphah International UniversityCompleted
-
Bastyr UniversitySeattle FoundationCompleted
-
The University of Hong KongCompleted
-
University of BarcelonaUniversity Ramon Llull; ICREA Academia; Institut de Neurociències de la Universitat... and other collaboratorsRecruiting
-
Florida International UniversityArizona State UniversityCompletedMental Health | Physical HealthUnited States